FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law Which non FDA (United States Food and Drug Administration) approved peptides, such as BPC 157 (Body Protection Compound 157) and TB 500 (Thymosin Beta 500), are likely legitimate for medical use under strict supervision?